Dashboard
Manage Tickers

MOALTRIA GROUP, INC.

NYSE altria.com


$ 53.14 $ -0.91 (-1.68 %)    

Wednesday, 11-Sep-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 468.28 $ 9.96 (2.17 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 53.17
$ 53.94
$ 53.14 x 100
$ 53.16 x 200
$ 52.54 - $ 53.94
$ 36.53 - $ 54.95
7,794,744
na
90.72B
$ 0.66
$ 8.93
TBD
na
na ($ 0.07)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2024 06-30-2024 10-Q
2 04-25-2024 03-31-2024 10-Q
3 02-27-2024 12-31-2023 10-K
4 10-26-2023 09-30-2023 10-Q
5 08-01-2023 06-30-2023 10-Q
6 04-27-2023 03-31-2023 10-Q
7 02-27-2023 12-31-2022 10-K
8 10-27-2022 09-30-2022 10-Q
9 07-28-2022 06-30-2022 10-Q
10 04-28-2022 03-31-2022 10-Q
11 02-25-2022 12-31-2021 10-K
12 10-28-2021 09-30-2021 10-Q
13 07-29-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 02-26-2021 12-31-2020 10-K
16 10-30-2020 09-30-2020 10-Q
17 07-30-2020 06-30-2020 10-Q
18 04-30-2020 03-31-2020 10-Q
19 02-25-2020 12-31-2019 10-K
20 10-31-2019 09-30-2019 10-Q
21 07-30-2019 06-30-2019 10-Q
22 04-25-2019 03-31-2019 10-Q
23 02-26-2019 12-31-2018 10-K
24 10-25-2018 09-30-2018 10-Q
25 07-26-2018 06-30-2018 10-Q
26 04-26-2018 03-31-2018 10-Q
27 02-27-2018 12-31-2017 10-K
28 10-26-2017 09-30-2017 10-Q
29 07-27-2017 06-30-2017 10-Q
30 05-02-2017 03-31-2017 10-Q
31 02-27-2017 12-31-2016 10-K
32 10-27-2016 09-30-2016 10-Q
33 07-27-2016 06-30-2016 10-Q
34 04-28-2016 03-31-2016 10-Q
35 02-25-2016 12-31-2015 10-K
36 10-29-2015 09-30-2015 10-Q
37 07-29-2015 06-30-2015 10-Q
38 04-23-2015 03-31-2015 10-Q
39 02-25-2015 12-31-2014 10-K
40 10-30-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

ubs-maintains-sell-on-altria-group-raises-price-target-to-41
UBS Maintains Sell on Altria Group, Raises...
09/09/2024 14:09:42

UBS analyst Faham Baig maintains Altria Group (NYSE:MO) with a Sell and raises the price target from $39 to $41.

barclays-maintains-underweight-on-altria-group-raises-price-target-to-45
Barclays Maintains Underweight on Altria G...
09/09/2024 13:38:40

Barclays analyst Gaurav Jain maintains Altria Group (NYSE:MO) with a Underweight and raises the price target from $43 to $45.

top-2-risk-off-stocks-that-may-crash-in-september
Top 2 Risk Off Stocks That May Crash In Se...
09/04/2024 13:06:41

b-of-a-securities-maintains-neutral-on-altria-group-raises-price-target-to-57
B of A Securities Maintains Neutral on Alt...
09/04/2024 12:11:39

B of A Securities analyst Lisa Lewandowski maintains Altria Group (NYSE:MO) with a Neutral and raises the price target from ...

altria-group-unusual-options-activity
Altria Group Unusual Options Activity
08/29/2024 14:46:46

Core News & Articles
FDA Issues Final Rule Increasing Minimum A...
08/29/2024 13:14:03

- Reuters 

altria-and-njoy-disagree-with-itc-judges-initial-ruling-favoring-juul-in-patent-dispute-plan-to-appeal-before-full-itc-njoy-pursues-alternative-resolution-and-fda-exemptions-to-continue-marketing-ace-product
Altria And NJOY Disagree With ITC Judge's ...
08/27/2024 12:09:26

Altria and NJOY respectfully disagree with the ALJ's initial determination, and NJOY looks forward to presenting its positi...

altria-group-increases-quarterly-dividend-by-41-from-098-to-102-per-share-payable-on-october-10-2024-to-shareholders-of-record-as-of-september-16-2024
Altria Group Increases Quarterly Dividend ...
08/22/2024 17:19:39

Core News & Articles
FDA Proposes Rule Requiring Submission Of ...
08/15/2024 15:09:31

- Reuters 

spotlight-on-altria-group-analyzing-the-surge-in-options-activity
Spotlight on Altria Group: Analyzing the S...
08/14/2024 19:30:41

barclays-maintains-underweight-on-altria-group-raises-price-target-to-43
Barclays Maintains Underweight on Altria G...
08/14/2024 14:31:07

Barclays analyst Gaurav Jain maintains Altria Group (NYSE:MO) with a Underweight and raises the price target from $37 to $43.

wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields
Wall Street's Most Accurate Analysts Give ...
08/08/2024 11:50:13

spotlight-on-altria-group-analyzing-the-surge-in-options-activity
Spotlight on Altria Group: Analyzing the S...
08/05/2024 18:01:04

this-is-what-whales-are-betting-on-altria-group
This Is What Whales Are Betting On Altria ...
08/02/2024 15:04:30

Core News & Articles
FDA Issues Warning Letters To Five Online ...
08/01/2024 15:38:59

- Reuters 

stifel-maintains-buy-on-altria-group-raises-price-target-to-54
Stifel Maintains Buy on Altria Group, Rais...
08/01/2024 14:20:15

Stifel analyst Matthew Smith maintains Altria Group (NYSE:MO) with a Buy and raises the price target from $50 to $54.

tech-stocks-on-track-for-best-session-in-5-months-ahead-of-fed-meeting-small-caps-target-highest-close-since-january-2022-whats-driving-markets-wednesday
Tech Stocks On Track For Best Session In 5...
07/31/2024 17:23:22

Tech stocks soared to their best session in five months on Wednesday, ahead of the highly anticipated Federal Open Market Commi...

altria-faces-q2-setbacks-eps-miss-cigarette-sales-plunge-but-smoke-free-innovations-shine
Altria Faces Q2 Setbacks: EPS Miss, Cigare...
07/31/2024 13:03:33

Altria Group shares fell after reporting a 3% decline in Q2 FY24 sales to $5.28 billion, missing the $5.39 billion consensus es...

wall-street-remains-on-track-for-amd-led-rebound-ahead-of-fed-decision-meta-earnings-analyst-says-the-bull-tends-to-remain-despite-near-term-volatility
Wall Street Remains On Track For AMD-Led R...
07/31/2024 11:55:46

Tech optimism is likely to abound on Wall Street as AI-levered stocks are feeding off the strength generated by Advanced Micro ...

altria-group-tightens-fy24-adj-eps-guidance-from-505-517-to-507-515-vs-510-est
Altria Group Tightens FY24 Adj EPS Guidanc...
07/31/2024 11:05:10

2024 Full-Year Guidance We narrow our guidance for 2024 full-year adjusted diluted EPS to be in a range of $5.07 to $5.15, rep...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION